The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Will Be The Estimated Market Size Of The Genetic Mutation Analysis Market By 2030?
The genetic mutation analysis market has seen substantial growth in recent years. Its value is predicted to rise from $6.65 billion in 2025 to $7.43 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. This historic expansion can be linked to several factors including limited access to advanced sequencing technologies, increasing awareness of genetic disorders, a surge in research related to oncology and inherited diseases, the widespread adoption of PCR and microarray technologies, and the initial progress in bioinformatics tools.
The genetic mutation analysis market is projected to undergo rapid expansion in the upcoming years, with its size expected to reach $11.47 billion in 2030, growing at a compound annual growth rate (CAGR) of 11.5%. This anticipated growth is primarily fueled by breakthroughs in CRISPR and NGS platforms, the expansion of pharmacogenomics research, heightened investments in genetic testing infrastructure, the adoption of AI-driven data interpretation tools, and increased collaborations between research institutes and biotech companies. Notable trends throughout the forecast period include the increasing uptake of next-generation sequencing and CRISPR technologies, a rising demand for personalized medicine and targeted therapies, the broader availability of genetic testing services in clinical diagnostics, the integration of bioinformatics and data analysis platforms, and an increase in research focused on rare genetic disorders and pharmacogenomics.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27297&type=smp
What Are The Main Drivers Accelerating The Growth Of The Genetic Mutation Analysis Market?
The increasing occurrence of genetic disorders is anticipated to drive the expansion of the genetic mutation analysis market in the coming years. Genetic disorders are conditions resulting from abnormalities or mutations in an individual’s DNA, which can be inherited or develop spontaneously. A contributing factor to the escalating prevalence of these disorders is advanced parental age, which elevates the risk of genetic mutations during reproduction and subsequently increases the likelihood of such disorders in offspring. Genetic mutation analysis plays a crucial role by detecting gene changes that indicate or cause genetic disorders, thereby enabling timely diagnosis, targeted therapeutic approaches, and well-informed reproductive or lifestyle decisions. For instance, in October 2024, data from the Cystic Fibrosis Trust, a UK-based charity, revealed that registered cystic fibrosis patients rose from 11,148 in 2022 to 11,318 in 2023, marking a 1.5% year-over-year increase in registrations. Consequently, the growing prevalence of genetic disorders is acting as a significant catalyst for the growth of the genetic mutation analysis market.
How Is The Genetic Mutation Analysis Market Examined Through Segment Analysis?
The genetic mutation analysis market covered in this report is segmented –
1) By Component: Hardware, Software, Services
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, Sanger Sequencing, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
3) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Genetic Disorders, Pharmacogenomics
4) By End User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories
Subsegments:
1) By Hardware: Sequencers, Polymerase Chain Reaction (PCR) Machines, Microarray Instruments, Electrophoresis Systems, Imaging Systems
2) By Software: Data Analysis Software, Sequence Alignment Tools, Variant Calling Software, Genome Annotation Software, Visualization Tools
3) By Services: Genetic Testing Services, Data Interpretation Services, Bioinformatics Services, Sample Preparation Services, Clinical Reporting Services
Which Trends Are Affecting The Genetic Mutation Analysis Market Framework?
Leading companies in the genetic mutation analysis market are concentrating on developing innovative solutions, such as tissue-based next-generation sequencing (NGS) tests, to enhance the precision of identifying actionable genetic alterations and to guide personalized treatment strategies. Tissue-based next-generation sequencing (NGS) tests are advanced diagnostic tools that analyze DNA or RNA from a tissue sample to detect genetic mutations, alterations, or biomarkers associated with diseases like cancer. For instance, in June 2024, Guardant Health Inc., a US-based oncology company, introduced the Guardant360 TissueNext test, which increases the number of genes it identifies in a tumor tissue sample to 498. These genes, serving as cancer biomarkers, enable oncologists to determine the most effective targeted therapies or treatment strategies for patients with advanced cancer. Beyond the panel expansion, Guardant has also refined the test’s operational workflow for a faster turnaround time. The new Guardant360 TissueNext test will receive coverage for Medicare fee-for-service patients with advanced solid tumor cancers as a standalone service, based on coverage conveyed by Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostics Services program (MolDX), under the existing local coverage determination.
Which Industry Players Are Present In The Genetic Mutation Analysis Market?
Major companies operating in the genetic mutation analysis market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies Plc, Genomic Health Inc., Color Genomics Inc., Blueprint Medicines Corporation, GENEWIZ Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Personalis Inc., LGC Biosearch Technologies LLC, BGI Genomics Co. Ltd.
Access The Complete Genetic Mutation Analysis Market Report:
https://www.thebusinessresearchcompany.com/report/genetic-mutation-analysis-global-market-report
Which Region Holds The Largest Share In The Genetic Mutation Analysis Market?
North America was the largest region in the genetic mutation analysis market in 2025. The regions covered in the genetic mutation analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Genetic Mutation Analysis Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=27297&type=smp
Browse Through More Reports Similar to the Global Genetic Mutation Analysis Market 2026, By The Business Research Company
Mining Equipment Market Report 2026
https://www.thebusinessresearchcompany.com/report/mining-equipment-global-market-report
Electric Mining Equipment Market Report 2026
https://www.thebusinessresearchcompany.com/report/electric-mining-equipment-global-market-report
Autonomous Mining Equipment Market Report 2026
https://www.thebusinessresearchcompany.com/report/autonomous-mining-equipment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model